• Home
  • Go To Cipherbio.com
  • Create a Free Cipherbio Account
  • Go To Cipherbio.com
  • Create a Free Cipherbio Account
  • Powered By CipherBio
    • Home

Subscribe

Enter an email address to sign up for our weekly digest.

Premium Investor Insights

$300B+ invested. 235 neuro companies. 321 indications with clinical stage pipeline details.

See Investor Insights
Gene Editing
CRISPRgene therapy

NPR Has Its Eye on Landmark Gene-Editing Experiment to Restore Vision

CipherBio Data TeamMay 12, 2021

We’ve been watching advances in gene therapy that bring hope to those who suffer vision loss or blindness due to genetic conditions. And we’re not the only ones. This just in:  NPR recently interviewed patients involved in a landmark study using a gene-editing technique called CRISPR. NPR is the first to interview these patients. READ MORE

Gene Therapy Insights
CRISPReye diseasesgene therapy

Gene Therapy Building Long-Awaited Momentum

CipherBio Data TeamMay 5, 2021

Gene therapy is one of the hottest, most eye-opening areas in the life sciences right now. Its earliest victories happened more than 30 years ago, but, since then, gene therapy has struggled to build momentum — until now.  Ashanthi DeSilva owes her life to that early success. READ MORE

Subscribe

Enter an email address to sign up for our weekly digest.

Premium Investor Insights

$300B+ invested. 235 neuro companies. 321 indications with clinical stage pipeline details.

See Investor Insights
Cipher Bio Logo

© 2021 SVB Financial Group. All rights reserved.

  • Privacy
  • Terms of Service
  • Contact